Search

everythinglearnresearchcommunity

for

Search:↓

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

The UV–Vis Spectrophotometry method effectively measures minoxidil in rat skin for alopecia treatment.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Melatonin-loaded microemulsion could be a promising treatment for hair loss.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Hair loss can be caused by stress, aging, and harmful substances that create an imbalance in the body's natural processes.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Hair loss gene found on chromosome 3q26.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.